A review links amino acid imbalance with processes involved in ALS
Original source
The Amino Acid-Neurodegeneration Axis: Excitotoxicity and Oxidative Stress as Context-Dependent Amplifiers of Metabolic Dysfunction. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Study type
- Review
- Studied in
- Human, Animal
A review describes disrupted amino acid regulation as a contributor to excitotoxicity, oxidative stress, mitochondrial dysfunction and protein aggregation in amyotrophic lateral sclerosis (ALS). It identifies possible research directions, including antioxidant support, receptor and transporter targeting, metabolic enzyme regulation and metabolic biomarkers.
Why this matters
The review may help researchers frame interconnected metabolic pathways and identify potential treatment targets or trial biomarkers. It does not show that these approaches work in people with ALS or change current treatment.
Limitations and context
This is a review, not a new clinical trial or treatment study. The source discusses mechanisms shared across several neurodegenerative diseases and describes translational potential, but does not establish clinical benefit, an effective intervention or a validated biomarker for ALS.